Medical Intelligence Quiz

Challenge Yourself, Build Your Knowledge

Semaglutide and GLP-1 Receptor Agonists in Type 2 Diabetes
Question 1 of 5

Which is most accurate regarding semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, used in the treatment of type 2 diabetes (T2D)?

Semaglutide is contraindicated in elderly patients

Semaglutide is contraindicated in patients with renal or hepatic disorders

Oral semaglutide is associated with significantly less adverse effects than subcutaneous semaglutide

Semaglutide is approved as a second-line treatment option that can be used in conjunction with metformin or insulin analogs

Topics

Diabetes

Quiz
Diabetic Retinopathy Take Quiz
Diabetic Kidney Disease Take Quiz
Type 2 Diabetes Screening Guidelines Take Quiz
Alcohol and Type 2 Diabetes Take Quiz
Type 2 Diabetes Treatment Recommendations Take Quiz
Semaglutide and GLP-1 Receptor Agonists in Type 2 Diabetes Take Quiz
Type 2 Diabetes and Nonalcoholic Fatty Liver Disease Take Quiz
Type 2 Diabetes and Exercise Interventions Take Quiz